ERBB2 and breast cancer: A recent study in patients with HER2-positive metastatic BC observed a temporal adjustment to the impact of disease, with patients having lived longer with the disease experiencing higher levels of HRQoL and also reporting lower productivity impairment than those recently diagnosed [21].